Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.88 USD | -1.90% |
|
+28.39% | +397.50% |
07-09 | Emergent Biosolutions, Johnson & Johnson Settle Dispute Over COVID-19 Vaccine Manufacturing | MT |
07-08 | Emergent, J&J settle COVID vaccine supply deal dispute | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+397.50% | 635M | |
+56.84% | 848B | |
+31.64% | 627B | |
+0.10% | 363B | |
+15.48% | 318B | |
+12.72% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.32% | 179B | |
+3.93% | 167B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Emergent BioSolutions : Benchmark Adjusts Price Target on Emergent Biosolutions to $120 From $150, Maintains Buy Rating